Swiss Parenterals Limited — Ephedrine Exporter Profile
Indian Pharmaceutical Exporter · #13 for Ephedrine · $348.5K export value · DGFT Verified
Swiss Parenterals Limited is the #13 Indian exporter of Ephedrine with $348.5K in export value and 14 verified shipments. Swiss Parenterals Limited holds a 1.5% market share in Ephedrine exports across 8 countries. The company exports 18 pharmaceutical products worth $15.9M across 9 therapeutic categories.
Swiss Parenterals Limited — Ephedrine Export Profile: Buyers & Destinations
Where Does Swiss Parenterals Limited Export Ephedrine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ALGERIA | $216.0K | 5 | 64.8% |
| PAPUA NEW GUINEA | $28.3K | 1 | 8.5% |
| SENEGAL | $26.5K | 1 | 7.9% |
| MALAYSIA | $22.8K | 1 | 6.8% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $20.0K | 1 | 6.0% |
| BENIN | $14.0K | 1 | 4.2% |
| ANGOLA | $5.8K | 3 | 1.7% |
| NICARAGUA | $1 | 1 | 0.0% |
Swiss Parenterals Limited exports Ephedrine to 8 countries. The largest destination is ALGERIA accounting for 64.8% of Swiss Parenterals Limited's Ephedrine shipments, followed by PAPUA NEW GUINEA (8.5%) and SENEGAL (7.9%). These destinations reflect Swiss Parenterals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ephedrine from Swiss Parenterals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PHARMACIE CENTRALE DES HOSPITAUX | ALGERIA | $125.8K | 3 |
| PHARMACIE CENTRALE DES HOPITAUX | ALGERIA | $90.2K | 2 |
| CITY PHARMACY LIMITED | PAPUA NEW GUINEA | $28.3K | 1 |
| SEN PHARMACIE NATIONALE DAPPROVISIO | SENEGAL | $26.5K | 1 |
| PHARMANIAGA LOGISTICS SDN. BHD. | MALAYSIA | $22.8K | 1 |
| MEDICO PLUS. | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $20.0K | 1 |
| SOBAPS S A | BENIN | $14.0K | 1 |
| KALPATARU REMEDIOS | ANGOLA | $5.8K | 3 |
| COFARCA S.A | NICARAGUA | $1 | 1 |
Swiss Parenterals Limited supplies Ephedrine to 9 buyers globally. The largest buyer is PHARMACIE CENTRALE DES HOSPITAUX (ALGERIA), followed by PHARMACIE CENTRALE DES HOPITAUX (ALGERIA) and CITY PHARMACY LIMITED (PAPUA NEW GUINEA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ephedrine Export Value and How Much Does Swiss Parenterals Limited Contribute?
India exported $9.8M worth of Ephedrine through 389 shipments from 59 suppliers to 56 countries, serving 116 buyers globally. Swiss Parenterals Limited contributes $348.5K to this total, accounting for 1.5% of India's Ephedrine exports. Swiss Parenterals Limited ships Ephedrine to 8 countries through 9 buyers.
What Is the Average Shipment Value for Swiss Parenterals Limited's Ephedrine Exports?
Swiss Parenterals Limited's average Ephedrine shipment value is $24.9K per consignment, based on 14 shipments totaling $348.5K. The largest destination is ALGERIA (64.8% of Swiss Parenterals Limited's Ephedrine exports).
How Does Swiss Parenterals Limited Compare to Other Indian Ephedrine Exporters?
Swiss Parenterals Limited ranks #13 among 59 Indian Ephedrine exporters with a 1.5% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.3M), LABORATE PHARMACEUTICALS INDIA LTD ($1.8M), GRANULES INDIA LIMITED ($1.4M). Swiss Parenterals Limited processed 14 shipments to 8 destination countries.
What Ephedrine Formulations Does Swiss Parenterals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EPHEDRINE INJECTION BP 30 MG/ML,1ML (60,000 BOXES) | $50.0K | 1 |
| EPHEDRINE INJECTION BP 30 MG/ML,1 ML (31 | $44.6K | 1 |
| EPHEDRINE INJECTION BP 30 MG/ML, 1 ML 3 | $41.0K | 1 |
| EPHEDRINE INJECTION BP 30 MG/ML,1ML (36,968 BOXES) | $40.2K | 1 |
| EPHEDRINE INJECTION BP 30 MG/ML, 1 ML ( | $40.1K | 1 |
| EPHEDRINE INJECTION BP 30 MG/ML,1 ML (48 | $28.3K | 1 |
| EPHEDRINE INJECTION BP 30MG/ML,1ML (70,000 AMPS)(EXPORT AUTHORISATION NO.PC/EXP-10201/2025 DATE.12.02.2025 | $26.5K | 1 |
| EPHEDRINE INJECTION (CONTAINING EPHEDRIN | $22.8K | 1 |
| EPHEDRINE INJECTION BP 50MG/ML, 1ML (20, | $20.0K | 1 |
| EPHEDRINE INJ BP 30 MG ML 1ML EXP AUTH NO PC EXP 112 2023 DT 30 01 23 IMP PERMITNO 136202200364 DT 15 12 22 24300 AMPS | $14.0K | 1 |
Swiss Parenterals Limited exports 12 distinct Ephedrine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EPHEDRINE INJECTION BP 30 MG/ML,1ML (60,000 BOXES) with 1 shipments worth $50.0K.
How Does Swiss Parenterals Limited Compare to Nearest Ephedrine Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | GLOBAL PHARMATECH PRIVATE LIMITED | $350.0K | 7 | 1 | $50.0K |
| 12 | MAIVA PHARMA PRIVATE LIMITED | $350.0K | 7 | 1 | $50.0K |
| 13 | SWISS PARENTERALS LIMITED ★ | $348.5K | 14 | 8 | $24.9K |
| 8 | GLAND PHARMA LTD | $250.0K | 5 | 1 | $50.0K |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LTD | $200.0K | 4 | 1 | $50.0K |
Swiss Parenterals Limited ranks #13 among 59 Indian Ephedrine exporters. Average shipment value of $24.9K compared to the market average of $166.9K. The closest competitors by value are GLOBAL PHARMATECH PRIVATE LIMITED and MAIVA PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Ephedrine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR | 57 | 14.7% |
| DELHI AIR CARGO ACC (INDEL4) | 37 | 9.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 28 | 7.2% |
| PATLI ICD | 28 | 7.2% |
| SAHAR AIR | 26 | 6.7% |
| BANGALORE AIR | 20 | 5.1% |
| HYDERABAD ACC (INHYD4) | 14 | 3.6% |
| BANGALORE ACC (INBLR4) | 13 | 3.3% |
Geopolitical & Trade Policy Impact on Swiss Parenterals Limited's Ephedrine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Swiss Parenterals. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended delivery times. Such maritime challenges can significantly impact the timely distribution of pharmaceuticals, especially to Middle Eastern markets. (pharmaceuticalcommerce.com)
Conversely, escalating US-China trade tensions have prompted the United States to diversify its import sources, potentially benefiting Indian exporters. However, recent US tariff policies, including a 25% tariff on Indian imports due to geopolitical alignments, pose a substantial challenge, potentially affecting nearly 55% of India's exports to the US. (apnews.com)
In the European Union, stringent regulatory frameworks like the Falsified Medicines Directive necessitate compliance with rigorous safety and quality standards. For companies like Swiss Parenterals, adhering to these regulations is crucial to maintain and expand their presence in EU markets.
Swiss Parenterals Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened scrutiny regarding quality and compliance. Indian exporters, including Swiss Parenterals, must navigate complex regulatory environments, ensuring adherence to FDA, WHO, and EU GMP standards. The US FDA's increased inspections of Indian facilities underscore the importance of maintaining high-quality manufacturing practices to avoid potential export bans or recalls. (fact.net.in)
Swiss Parenterals' integration into Eris Lifesciences is expected to bolster its compliance infrastructure, leveraging Eris's established quality management systems to meet international regulatory requirements effectively.
About Swiss Parenterals Limited
Swiss Parenterals Limited exports 18 products worth $15.9M. Beyond Ephedrine, top products include Ceftriaxone, Meropenem, Prednisolone, Fosfomycin, Methylprednisolone. View the complete Swiss Parenterals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ephedrine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ephedrine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Swiss Parenterals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 14 individual customs records matching Swiss Parenterals Limited exporting Ephedrine, covering 12 formulations to 8 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 56+ countries, 116+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ephedrine Export Data from Swiss Parenterals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Swiss Parenterals Limited's Ephedrine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Swiss Parenterals Limited
Full Company Profile →
18 products · $15.9M total trade · 9 categories
Ephedrine Stats
Company Overview
Top Products by Swiss Parenterals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Swiss Parenterals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ephedrine. For current shipment-level data, contact TransData Nexus.